Completed NA INTERVENTIONAL 2-arm NCT03820206

The Value of Tranxemic Acid to Reduce Intraoperative Blood Loss During Elective Cesarean Sections in High Risk Women

The Value of Tranxemic Acid to Reduce Intraoperative Blood Loss During Elective Cesarean Sections in High Risk Women: A Randomized Controlled Trial

Sponsor: Cairo University

Conditions Intraoperative Bleeding

Interventions Cesarean section Tranexamic Acid

Updated 5 times since 2019 Last updated: Jan 2, 2020 Started: Jan 31, 2019 Primary completion: Nov 15, 2019 Completion: Jan 2, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Intraoperative Bleeding and is currently completed. Cairo University leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA

Status: Not Yet Recruiting → Completed
Feb 2019 — Feb 2020 [monthly]

Not Yet Recruiting NA

First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cairo University

Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt